Halberd Corporation (HALB)
OTCMKTS · Delayed Price · Currency is USD
0.0018
+0.0001 (4.65%)
Aug 26, 2025, 3:09 PM EDT
Halberd Company Description
Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases.
It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer’s and Parkinson’s disease, cancer, blood-borne, and cerebrospinal fluid related diseases.
The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.
Halberd Corporation
| Country | United States |
| Founded | 2009 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 3 |
| CEO | William Hartman |
Contact Details
Address: PO Box 25 Jackson Center, Colorado 16133 United States | |
| Phone | 814 786 8849 |
| Website | halberdcorporation.com |
Stock Details
| Ticker Symbol | HALB |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | August - July |
| Reporting Currency | USD |
| ISIN Number | US4053311092 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| William A. Hartman | President, Chief Executive Officer and Chairman |
| John S. Borza AVS, MBA, PE | Chief Operating Officer and Director |
| Heidi H. Carl | Director and Accounting Director |
| Dr. Mitchell S. Felder M.D. | Chief Technology Officer and Member of the Scientific Advisory Board |
| Dr. Patricio F. Reyes FAAN, M.D. | Chief Mechanical Officer and Member of the Scientific Advisory Board |